Imaging cognitive impairment and impulse control disorders in parkinson's disease

Dementia and mild forms of cognitive impairment as well as neuropsychiatric symptoms (i. e., impulse control disorders) are frequent and disabling non-motor symptoms of Parkinson's disease (PD). The identification of changes in neuroimaging studies for the early diagnosis and monitoring of the...

Descripción completa

Detalles Bibliográficos
Autores: Martín-Bastida, A. (Antonio)|||/items/4467217c-f214-47ed-9407-5804d5ac2204, Delgado-Alvarado, M. (Manuel)|||/items/a4951956-75a5-4b50-872b-6291081c0681, Navalpotro-Gómez, I. (Irene)|||/items/a41b8eef-5add-4298-94c1-2bda081cb6d5, Rodriguez-Oroz, M.C. (María Cruz)|||/items/ba71432e-1a59-4a6d-87af-ba74627ba030
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/112444
Acceso en línea:https://hdl.handle.net/10171/112444
Access Level:acceso abierto
Palabra clave:Impulse control disorders (ICD)
Parkinson’s disease dementia (PDD)
Mild cognitive impairment (MCI)
Magnetic resonance imaging (MRI)
Positron emission tomography (PET)
Single photon computed tomography (SPECT)
Descripción
Sumario:Dementia and mild forms of cognitive impairment as well as neuropsychiatric symptoms (i. e., impulse control disorders) are frequent and disabling non-motor symptoms of Parkinson's disease (PD). The identification of changes in neuroimaging studies for the early diagnosis and monitoring of the cognitive and neuropsychiatric symptoms associated with Parkinson's disease, as well as their pathophysiological understanding, are critical for the development of an optimal therapeutic approach. In the current literature review, we present an update on the latest structural and functional neuroimaging findings, including high magnetic field resonance and radionuclide imaging, assessing cognitive dysfunction and impulse control disorders in PD.